Skip to content
2000
Volume 20, Issue 4
  • ISSN: 2772-4344
  • E-ISSN: 2772-4352

Abstract

Introduction

Fever of Unknown Origin (FUO) was first defined in 1961 as a temperature greater than 38.3°C on several occasions, lasting for more than 3 weeks, or failure to reach a diagnosis despite one week of inpatient investigation. The time frame has recently been revised to include patients whose illness remains undiagnosed after either a minimum of three outpatient visits or three days of hospitalization. The purpose of this study was to describe the etiology, frequency, and pattern of different causes, particularly infectious causes, and to determine the relative incidence of various causes of FUO in the mid-Delta area of Egypt.

Methods

This retrospective cohort study included all FUO cases registered in the file system over a seven-year period from 2015 to 2022 at Mahala-Kubra Fever Hospital, as well as all admitted FUO cases at the Tropical Medicine and Infectious Diseases Department of Tanta University during 2021 and 2022.

Results

A total of 383 FUO cases were included in the study. Among these, the leading causes of FUO were infections (n = 334, 87.2%), followed by neoplasms (n = 26, 6.8%). Autoimmune and miscellaneous causes ranked third (n = 9, 2.3%), and undiagnosed cases were the least common (n = 5, 1.3%). The two most common infectious causes in this study were urinary tract infection (n = 136, 40.7%) and brucellosis (n = 115, 34.4%). Typhoid fever (n = 29, 8.7%), pneumonia (n = 15, 4.2%), and abscesses (n = 10, 3.0%) were also frequent causes of FUO. Hematological malignancies were the most common malignant causes of FUO, with lymphoma being the most prevalent (n = 10, 38.5%), followed by leukemia (n = 8, 30.8%).

Conclusion

Fever (pyrexia) of unknown origin remains one of the most challenging complexities in medical diagnosis. Infections, particularly Urinary Tract Infections (UTIs) and brucellosis, are the primary causes of FUO in this study. It is also important to recognize that hematological malignancies are a significant cause of FUO.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/raaidd/10.2174/0127724344345490250605065612
2025-11-01
2025-12-09

  • From This Site

    /content/journals/raaidd/10.2174/0127724344345490250605065612
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. PetersdorfR.G. BeesonP.B. Fever of unexplained origin: Report on 100 cases.Medicine196140113010.1097/00005792‑196102000‑00001 13734791
     [Google Scholar]
  2. VanderschuerenS. KnockaertD. AdriaenssensT. From prolonged febrile illness to fever of unknown origin: The challenge continues.Arch. Intern. Med.200316391033104110.1001/archinte.163.9.1033 12742800
     [Google Scholar]
  3. DurackD.T. StreetA.C. Fever of unknown origin-reexamined and redefined.Curr. Clin. Top. Infect. Dis.1991113551 1651090
     [Google Scholar]
  4. Bleeker-RoversC.P. VosF.J. de KleijnE.M.H.A. A prospective multicenter study on fever of unknown origin: The yield of a structured diagnostic protocol.Medicine2007861263810.1097/MD.0b013e31802fe858 17220753
     [Google Scholar]
  5. HandaR. SinghS. SinghN. WaliJ.P. Fever of unknown origin: A prospective study.Trop. Doct.199626416917010.1177/004947559602600411 8937233
     [Google Scholar]
  6. BaicusC. BolosiuH.D. TanasescuC. BaicusA. Fever of unknown origin—predictors of outcome.Eur. J. Intern. Med.200314424925410.1016/S0953‑6205(03)00075‑X 12919841
     [Google Scholar]
  7. LiuK.S. ShengW.H. ChenY.C. ChangS.C. HsiehW.C. Fever of unknown origin: A retrospective study of 78 adult patients in Taiwan.J. Microbiol. Immunol. Infect.2003364243247 14723252
     [Google Scholar]
  8. Arce-SalinasC.A. Morales-VelázquezJ.L. Villaseñor-OviesP. Muro-CruzD. Classical fever of unknown origin (FUO): Current causes in Mexico.Rev. Invest. Clin.2005576762769 16708901
     [Google Scholar]
  9. SipahiO.R. SenolS. ArsuG. Pooled analysis of 857 published adult fever of unknown origin cases in Turkey between 1990-2006.Med. Sci. Monit.2007137CR318CR322 17599026
     [Google Scholar]
  10. HuY. LuH. ZhangY. Fever of unknown origin: Revisit of 142 cases in a tertiary Chinese hospital.Biosci. Trends2008214446 20103898
     [Google Scholar]
  11. MoawadM.A. BassilH. ElsherifM. Fever of unknown origin: 98 cases from Saudi Arabia.Ann. Saudi Med.201030428929410.4103/0256‑4947.65259 20622346
     [Google Scholar]
  12. KejariwalD. SarkarN. ChakrabortiS.K. AgarwalV. RoyS. Pyrexia of unknown origin: A prospective study of 100 cases.J. Postgrad. Med.2001472104107 11832599
     [Google Scholar]
  13. AbdelbakyM.S. MansourH.E. IbrahimS.I. HassanI.A. Prevalence of connective tissue diseases in Egyptian patients presenting with fever of unknown origin.Clin. Med. Insights Arthritis Musculoskelet. Disord.20114334110.4137/CMAMD.S6763
     [Google Scholar]
  14. MahmoodK. AkhtarT. NaeemM. TalibA. HaiderI. Siraj-Us-Salikeen. Fever of unknown origin at a teritiary care teaching hospital in Pakistan.Southeast Asian J. Trop. Med. Public Health2013443503511 24050083
     [Google Scholar]
  15. AlaviS.M. NadimiM. ZamaniG.A. Changing pattern of infectious etiology of fever of unknown origin (FUO) in adult patients in Ahvaz, Iran.Caspian J. Intern. Med.201343722726 24009968
     [Google Scholar]
  16. BeheraS. SubrahmanyamD.K.S. BajpaiJ. PradhanA. SinghA. Clinical and etiological spectrum of prolonged fever and special reference to HIV patients at a tertiary care centre.Int. J. Res. Med. Sci.201867224310.18203/2320‑6012.ijrms20182454
     [Google Scholar]
  17. MontasserM.F. AbdelkaderN.A. MontasserI.F. KhoulyA.M.E. Changing the face of fever of unknown origin in Egypt: A single hospital study.Braz. J. Infect. Dis.201519333433510.1016/j.bjid.2015.02.006 25911088
     [Google Scholar]
  18. Pan-panZ. JianL. Analysis of etiology of unexplained fever cases reported in Chinese literature in the past 10 years.Elect J Emerg Infect Diseas201834221
     [Google Scholar]
  19. BosilkovskiM. DimzovaM. CvetkovaM. PoposkiK. SpasovskaK. VidinicI. The changing pattern of fever of unknown origin in the Republic of North Macedonia.Rom. J. Intern. Med.201957324825310.2478/rjim‑2019‑0007 30862765
     [Google Scholar]
  20. ZhouG. ZhouY. ZhongC. Retrospective analysis of 1,641 cases of classic fever of unknown origin.Ann. Transl. Med.202081169010.21037/atm‑20‑3875 32617310
     [Google Scholar]
  21. AliM. JamesO.C. MohamedA.A. JoachimA. MubiM. OmodiorO. Etiologic agents of fever of unknown origin among patients attending Mnazi Mmoja hospital, Zanzibar.J. Community Health20204551073108010.1007/s10900‑020‑00832‑w 32399732
     [Google Scholar]
  22. Vector-borne diseases.2024https://www.emro.who.int/egy/programmes/neglected-tropical-diseases.html
  23. SzymanskiA.M. CliffordH. RonisT. Fever of unknown origin: A retrospective review of pediatric patients from an urban, tertiary care center in Washington, DC.World J. Pediatr.202016217718410.1007/s12519‑019‑00237‑3 30888665
     [Google Scholar]
  24. KarabelaŞ.N. KartY.K. Fever of unknown origin: Evaluation of 110 classical and HIV-associated cases in the last decade.Hosp. Pract.202250322222710.1080/21548331.2020.1775453 32520649
     [Google Scholar]
  25. ErdemH. BaymakovaM. AlkanS. Classical fever of unknown origin in 21 countries with different economic development: An international ID-IRI study.Eur. J. Clin. Microbiol. Infect. Dis.202342438739810.1007/s10096‑023‑04561‑5 36790531
     [Google Scholar]
  26. JiangL. WuH. ZhaoS. ZhangY. SongN. Structured diagnostic scheme clinical experience sharing: A prospective study of 320 cases of fever of unknown origin in a tertiary hospital in North China.BMC Infect. Dis.202323145210.1186/s12879‑023‑08436‑0 37420165
     [Google Scholar]
  27. HuB. ChenT.M. LiuS.P. Fever of unknown origin (FUO) in children: A single-centre experience from Beijing, China.BMJ Open202212304984010.1136/bmjopen‑2021‑049840 35296470
     [Google Scholar]
  28. TornéC.J. BaucellsA.J.M. BlanchF.J. CamellI.H. Fiebre de origen desconocido clásica: Análisis de una cohorte de 87 pacientes según la definición con criterio de estudio cualitativo.Med Clín2021156520621310.1016/j.medcli.2020.03.014 32593415
     [Google Scholar]
  29. NguyenT.K. NguyenY.H. NguyenH.T. KhongQ.M. TranN.K. Etiologies of fever of unknown origin in HIV/AIDS patients, Hanoi, Vietnam.BMC Infect. Dis.20222216110.1186/s12879‑022‑07049‑3 35042469
     [Google Scholar]
  30. SamahaH. Al-RowailyM. KhoudairR.M. AshourH.M. Multicenter study of brucellosis in Egypt.Emerg. Infect. Dis.200814121916191810.3201/eid1412.071452 19046520
     [Google Scholar]
  31. ElhaigM.M. WahdanA. Seroprevalence, associated risk factors, and molecular detection of bovine brucellosis in rural areas of Egypt.Comp. Immunol. Microbiol. Infect. Dis.20239510197110.1016/j.cimid.2023.101971 36921504
     [Google Scholar]
  32. JacobsM. Imported fever: A survival guide.J. R. Soc. Med.200093312412810.1177/014107680009300305 10741311
     [Google Scholar]
  33. BottieauE. ClerinxJ. SchrootenW. Etiology and outcome of fever after a stay in the tropics.Arch. Intern. Med.2006166151642164810.1001/archinte.166.15.1642
     [Google Scholar]
  34. TabakF. MertA. CelikA.D. Fever of unknown origin in Turkey.Infection200331641742010.1007/s15010‑003‑3040‑6 14735385
     [Google Scholar]
  35. KucukardaliY. OnculO. CavusluS. The spectrum of diseases causing fever of unknown origin in Turkey: A multicenter study.Int. J. Infect. Dis.2008121717910.1016/j.ijid.2007.04.013 17629532
     [Google Scholar]
  36. Abdel-GawadM. ZaghloulM.S. Abd-elsalamS. Post-COVID-19 syndrome clinical manifestations: A systematic review.Antiinflamm. Antiallergy Agents Med. Chem.202121211512010.2174/1871523021666220328115818 35346011
     [Google Scholar]
  37. ElfertA. Abo AliL. SolimanS. IbrahimS. Abd-ElsalamS. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.Eur. J. Gastroenterol. Hepatol.201628121450145410.1097/MEG.0000000000000724 27512927
     [Google Scholar]
  38. Abd-ElsalamS. NoorR.A. BadawiR. Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study.J. Med. Virol.202193105833583810.1002/jmv.27122 34076901
     [Google Scholar]
  39. MohamedA.A. MohamedN. MohamoudS. SARS-CoV-2: The path of prevention and control.Infect. Disord. Drug Targets202121335836210.2174/22123989MTA2gODAe1 32433010
     [Google Scholar]
  40. QiL. HuangY. LiuZ. Multidimensionally nano-topologized polycaprolactone fibrous membrane anchored with bimetallic peroxide nanodots for microenvironment-switched treatment on infected diabetic wounds.Adv. Fiber Mater.2024661777179710.1007/s42765‑024‑00447‑z
     [Google Scholar]
  41. LiuW. ZhaoW. XieK. Toughening and responsive contractile shape memory fibrous membrane via water for mechanically active wound dressing.Adv. Fiber Mater.2024661942195410.1007/s42765‑024‑00463‑z
     [Google Scholar]
/content/journals/raaidd/10.2174/0127724344345490250605065612
Loading
Aetiology of Fever of Unknown Origin in Two Middle Delta Egyptian Tertiary Health Care Facilities
Recent Adv Antiinfect Drug Discov 20, 338 (2025); https://doi.org/10.2174/0127724344345490250605065612
/content/journals/raaidd/10.2174/0127724344345490250605065612
/content/journals/raaidd/10.2174/0127724344345490250605065612
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): autoimmune diseases; bacteria; fungi; infections; malignancy; parasites; Urinary tract infections (UTIs); viruses

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test